NICE climbdown over anti-flu drug Relenza

Posted on September 1st, by editor in Caring Times. No Comments

Elderly people in care homes are among those who will benefit from a change of heart by the National Institute of Clinical Excellence (NICE) with regard to the anti-flu drug Relenza. NICE reversed a decision last year not to make the drug available on the NHS, and now says that people over 65, those with respiratory disease, those with lowered resistance to infection (for example, those with diabetes) should have access to the drug when flu is “circulating in the community”. Official guidelines suggest that this occurs when 50 to 400 cases of flue occur per 100,000 GP consultations. Vaccination remains the mainstay of preventing flu in all those at risk, but Relenza will, in some patients, reduce the chances of developing flu, and may reduce the length and severity of the illness.

Comments are closed.

Latest blog posts

Care homes discounted in end of life care

By Caring Times editor GEOFF HODGSON

I am sure that we all want those who we care for to experience ‘a good death’ when the time...

Perhaps I’m ‘app’athetic

By Caring Times editor GEOFF HODGSON

I’ve got an app in my toolbox that allows me to bang-in nails – I call it a hammer. I’ve...

Fond memories of long distance discomfort

By Caring Times editor GEOFF HODGSON

The Ford Anglia, the earliest models of which were built in 1939, was a great car for a small family;...